Healthcare Enterprise Group market a product called "Ebiox" which is one of a very few that can kill most bacteria including the MRSA superbug. HCEG has contracts with some NHS hospitals at present, but given the recent and current news and public attention, HCEG should be a good bet for a steady rise as more places seek to cut the number of casualties from this infection. HCEG also market abroad in USA, so the potential market for this unique product is massive indeed.

Well worth a punt IMHO

Check it out for yourself

Over 1m sells so far this morning and no sells - price holding.

Looks as if I might be able to get some @ my 50p target (2p in old money).

Always seems to be the case after a consolidation - from bitter experience.

Active this AM more than half a milliom shares traded by 8.07

Looking good

3.8 million shares traded now, mostly recorded as sells! now that surely can't be the true picture or they should be down as much as they are up.
As it is nice volume price rising....good sign!!

bid up at 74p some huge buys late on yesterday obviously MM's desperate to buy does that mean large buyers in the background?,

It's not just Ebiox which promises so much,I'm also interested in the range of disposable endoscopes produced by Optiscope Technologies,in which HCEG has increased its holding to 66.25%A first run of 1000 prototypes will be clinically tested within two months.This is almost as interesting as Ebiox.No more cold metal objects ......etc.In today's filthy hospitals everything should be sterilised and disposable.I bought some yesterday...gone rigid today...what should the price be that I can hope for?Shares,not endoscopes,that is.Ethel

Nice to see this one keeps making new highs.

six days and no one has answered my question..is anyone out there a buyer,like me??This has GOT to ROCKET:..

I'm a holder. I don't have a target. This is simply an excellent company with superb growth potential which has already almost doubled the money I put into it. I expect a lot more over the next couple of years.

doug

OK ethel, you and Doug are not on your own, I'm a holder. Not been in very long but showing a small gain. Soon as Ebiox gets accepted by our NHS who at the present time appear not to be rushing around about MRSA then HCEG must move into a different league.
opto

had 'em for a year now and quite content with slow upwardly mobile progress I expected with the present announced increase in the MRSA scandal they may of risen, but unless people are aware of them then they'll not.The institutions are keeping a tight handle on them.

According to INTEK on A.D.F.V.N. here is the present breakdown of ownership as of the 7th Feb

Directors and key personnel = 45%
Institutions = 43%
Free float = 12%

So there ain't many around so plenty of buying will send it rising.

Thanks for that...I am not alone.Also bt. AMS at the same time; they flew up in a flurry and then landed back where I found them.This also has to be a good investment.UPANDDOWN...thankyou for info,did'nt realise they only have such a small free float.Does'nt this make them harder to sell in a falling mkt?Also,the spread is controlled more by THEM than us...(is'nt it anyway...so much for free market forces out there.)

rising again today until the last deal of the day they were up a further 1.5p on bid

they are just about the easiest share to sell, the mms will bite your hand off.
the Institutions just can't get enough of them and there are some big announcements in the pipeline.

The more I read about HCEG,the more impressed I am by their sensible way of conducting the business.They have more than doubled their mkt cap since the same time,last year.When investors worried about the amount of shares and warrants HCEG had in the market,the company reacted in the right way.When buying a new business,they usually buy around half that company and when the time is right buy out the remaining minority interest in return for shares in HCEG plus a cash consideration. Mr Mcgregor,the previous owner of Ebiox Ltd.,will be paid in tranches of shares depending upon the success of Ebiox Handrub.He will also receive royalties for the next five years,depending on sales.The fact that Mr Mcgregor has agreed to these terms shows how secure he feels about the future success of Ebiox wipes and sprays.In the case of Gordon Wood,the founder of SafaTec(Israel),the holding company for Ebiox and Optiscope that HCEG completed buying this year,he will not be able to sell any shares he receives as payment for a year from issue date.Mr Wood is now COO of HCEG.Did you know that Ebiox was first designed to counter chemical warfare agents?Ebiox IS potentially the blockbuster in their portfolio of products and they are expecting a favourable report from trial runs in NHS hospitals.But I see applications in the catering industry as well as in medical/laboratory situations.Plus,Ebiox is claimed to be effective against the SARS virus as well as PARVOVIRUS,affecting dogs.Two thirds of nurses questioned said that they were allergic to alcohol based hand washes.Ebiox Handrub demonstrated a 99.999% reduction in ALL test organisms within 30 seconds.What more can I say:This is no longer in the class of tiddler penny shares,it has the capacity to be a really good investment.Ethel...IMHO

HCEG are into all sorts of things from Optiscope thru to Airway devices.If you look at the websites of the various company's of which HCEG has an interest you'll be amazed at the numerous products they're involved with.They are far and away from a one product firm as seems to be the general consensus.It's still not too late and one to pack away for the long term.

Nice start to the day. At last we may see a re-rating

RNS Number:1608J
Healthcare Enterprise Group PLC
01 March 2005

Ebiox surface disinfectant, test results

Proven combatant ability against HIV and Avian Flu

Healthcare Enterprise Group PLC ("HCEG"), the international healthcare products
and Services Company announces that its TrionicTM product, from the Ebiox family of products, has passed tests proving virucidal efficacy against the HIV and
Avian Flu ( Bird Flu) viruses.

The tests, conducted by Microbiotest Inc of Sterling, Virginia, USA conclude that using Trionic in a range of different levels of dilution, applicable to the test, the two viruses became undetectable.

Reports this week surrounding the failure to reduce death rates from MRSA in the
UK and the need to remain vigilant with HIV, highlighted once again the need to
improve hygiene practices on our own doorstep.

However, the problem of cross contamination is much more widespread as evidenced by the growing fear surrounding the spread of Avian Flu around the world.

According to the World Health Organisation, Avian Flu viruses can be readily
transmitted from farm to farm by mechanical means, such as contaminated
equipment, vehicles and cages.

Stringent sanitary measures on farms can confer some degree of protection, including hand hygiene and surface cleaning and disinfection. HCEG recently completed agreement with Alpha Trading (Asia) Co Ltd covering the distribution of Ebiox throughout Asia and reports encouraging initial demand driven by the Avian Flu crisis.

TrionicTM is a highly effective disinfectant already proven to combat MRSA,
SARS and other pathogens.

The product offers significant safety advantages over all other commonly used disinfectants and does not contain alcohol, chlorine or other irritating vapours. Moreover, TrionicTM contains soil lifting agents and biocides, which allow removal of microbes down to the molecular level, by removing biofilms, which are believed to provide a rich breeding ground for the development of resistant bacteria.

Many of the disinfectants currently used are ineffective in dirty conditions, when soiling is present. TrionicTM works differently, cleaning, disinfecting and deodorising in one to provide complete decontamination.

Stuart Bruck, Chairman, Healthcare Enterprise Group PLC, commented:

"Avian Flu has been described as the number one health threat in the world and
huge resources are being channelled at controlling the disease which has a 76%
fatality rate.

As with HIV, MRSA, SARS and all other deadly diseases, the microbes can harbour on surface areas, hence the need to regularly decontaminate. TrionicTM, through its unique properties, eradicates all surface microbes and pathogens without the problem of resistant strains forming.

"We plan to market TrionicTM aggressively across all relevant industry sectors
internationally, thus affording rapid deployment to combat this serious
international problem."

Still motoring. Nothing to stop this now!!